Breaking Down Adeka Corporation Financial Health: Key Insights for Investors

Breaking Down Adeka Corporation Financial Health: Key Insights for Investors

JP | Basic Materials | Chemicals - Specialty | JPX

Adeka Corporation (4401.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether Adeka Corporation (4401.T) is a buy, hold or watch? Start here: in the fiscal year ending March 31, 2025 Adeka posted net sales of ¥407,145 million (up 1.8% year-over-year) with TTM revenue of ¥407,780 million as of Sept 30, 2025 and revenue per employee of ¥74.78 million, while a market capitalization near ¥381.78 billion yields a P/S of 0.94; operating profit reached ¥39,200 million (margin ~9.6%, up from 8.8%), EPS is projected at ¥236.95 and management targets ROE 11% and ROIC 10.5% for FY2025-balanced by a conservative balance sheet (total assets ¥700,000 million, liabilities ¥300,000 million, debt-to-equity 0.5, equity-to-asset 56.3%), a planned ¥18 billion share repurchase, solid liquidity (current ratio 1.8, quick ratio 1.2), H1 operating cash flow ¥15,000 million and free cash flow ¥10,000 million, manageable leverage (net debt/EBITDA 1.2, interest coverage ~10x), and a valuation profile showing P/E 14.97, forward P/E 13.52, P/B 1.2, dividend ¥104 (yield 2.72%, ex-dividend Mar 30, 2026) amid analyst targets of ¥3,200-¥3,733; weigh these metrics alongside material risks-raw material price swings, competitive pressures, regulatory and currency volatility-and growth levers like the ADX 2026 plan, nearly 55% international sales ratio and a pivot to high-value chemicals to decide your next move.

Adeka Corporation (4401.T) - Revenue Analysis

Adeka Corporation (4401.T) reported steady revenue trends through fiscal year ending March 31, 2025, with minor year-over-year improvements and consistent per-employee productivity indicators.
  • Net sales (FY ended Mar 31, 2025): ¥407,145 million - +1.8% vs prior fiscal year.
  • First half FY2025 net sales: ¥195,710 million - +0.3% vs prior first half.
  • TTM revenue as of Sep 30, 2025: ¥407,780 million - +0.15% YoY.
  • Revenue growth: FY2025 +1.84% vs FY2024 which was -0.89%.
  • Revenue per employee: ≈ ¥74.78 million (5,453 employees).
  • Market capitalization: ~¥381.78 billion; Price-to-Sales (P/S): 0.94.
Metric Value Period/Notes
Net Sales ¥407,145 million FY ended Mar 31, 2025
First Half Net Sales ¥195,710 million H1 FY2025
TTM Revenue ¥407,780 million As of Sep 30, 2025
YoY Revenue Change (FY2025) +1.84% vs FY2024
YoY Revenue Change (FY2024) -0.89% Prior year
Revenue per Employee ¥74.78 million 5,453 employees
Market Capitalization ¥381.78 billion Market value
Price-to-Sales (P/S) 0.94 Market cap / TTM revenue
  • Stability: Revenue swings are muted - single-digit percentage moves indicating stable demand or pricing environment.
  • Productivity: ¥74.78 million revenue per employee suggests moderate operational efficiency relative to peers in specialty chemicals and materials.
  • Valuation context: P/S of 0.94 positions the company near parity between market cap and annual sales; investors should compare margins and growth vs peers.
  • Short-term momentum: Minimal H1 and TTM increases (~0.3% and 0.15%) signal tepid near-term acceleration despite FY improvement.
Adeka Corporation: History, Ownership, Mission, How It Works & Makes Money

Adeka Corporation (4401.T) - Profitability Metrics

Adeka Corporation (4401.T) reported improved operating profitability and set higher returns targets for fiscal year 2025 while maintaining stable net margin levels. Key headline figures for FY2025 and comparable FY2024 metrics are presented below.
  • Operating profit (FY2025): ¥39,200 million - a 5.5% increase from the previous forecast.
  • Operating profit margin (FY2025): ~9.6% (up from 8.8% in FY2024).
  • Net profit margin (FY2025): 5.7% (FY2024: 5.8%).
  • Earnings per share (EPS) (FY2025, projected): ¥236.95 - a 5.2% increase from the previous forecast.
  • Return on equity (ROE) target (FY2025): 11.0% (FY2024: 10.0%).
  • Return on invested capital (ROIC) target (FY2025): 10.5% (FY2024: 10.0%).
Metric FY2024 FY2025 (Target / Projected) Change / Note
Operating Profit (¥ million) - 39,200 +5.5% vs previous forecast
Operating Profit Margin 8.8% 9.6% Improved by 0.8 percentage points
Net Profit Margin 5.8% 5.7% Marginal decline of 0.1 percentage points
EPS (¥) - 236.95 Projected +5.2% vs prior forecast
ROE 10.0% 11.0% Target increase of 1.0 percentage point
ROIC 10.0% 10.5% Target increase of 0.5 percentage points
  • Improved operating margin (9.6%) signals better core profitability and/or cost control despite a slight dip in net margin (5.7%)-likely due to non-operating items or tax/one-off impacts.
  • EPS uplift (¥236.95) combined with higher ROE and ROIC targets indicates management focus on shareholder returns and capital efficiency.
  • Investors should monitor whether operating profit growth sustains and whether net margin pressure is transitory.
Adeka Corporation: History, Ownership, Mission, How It Works & Makes Money

Adeka Corporation (4401.T) - Debt vs. Equity Structure

Adeka Corporation (4401.T) demonstrates a conservative capital structure with a clear emphasis on equity funding and manageable leverage metrics in fiscal 2025. The company's balance sheet trends and announced shareholder actions indicate both strengthened solvency and an intent to enhance returns.
  • Equity-to-asset ratio: 56.3% (H1 FY2025), up from prior periods, reflecting improved capitalization.
  • Total assets (as of Sep 30, 2025): ¥700,000 million; Total liabilities: ¥300,000 million.
  • Implied shareholders' equity: ¥400,000 million (calculated from assets - liabilities), yielding a debt-to-equity ratio of 0.5.
  • Liability mix: Long-term debt = 40% of total liabilities; Short-term debt = 60% of total liabilities.
  • Interest coverage ratio (FY2025 projected): 10×, indicating strong ability to service interest expense.
  • Debt-to-equity ratio trend: stable over the past three years, showing consistent financial leverage management.
  • Share repurchase program: up to ¥18 billion (Aug 2025-May 2026) targeted at boosting shareholder returns and supporting EPS.
Item Amount (¥ million) Note
Total Assets (30 Sep 2025) 700,000 Reported
Total Liabilities (30 Sep 2025) 300,000 Reported
Shareholders' Equity (Implied) 400,000 Assets - Liabilities
Equity-to-Asset Ratio (H1 FY2025) 56.3% Stronger capitalization
Debt-to-Equity Ratio 0.5 Liabilities / Equity
Long-term Debt 120,000 40% of total liabilities (300,000 × 0.4)
Short-term Debt 180,000 60% of total liabilities (300,000 × 0.6)
Interest Coverage Ratio (FY2025 proj.) 10× EBIT / Interest expense
Share Repurchase Authorization ¥18,000 million Aug 2025 - May 2026
  • Leverage profile: With a 0.5 debt-to-equity ratio and equity comprising 56.3% of assets, Adeka sits comfortably below aggressive leverage thresholds common in chemicals and specialty materials sectors.
  • Liquidity and refinancing risk: Short-term debt represents 60% of liabilities, requiring active working capital and liquidity management despite strong interest coverage.
  • Shareholder actions: The ¥18 billion buyback is a sizable use of capital relative to equity (≈4.5% of implied equity), signaling confidence in cash generation and an effort to enhance per-share metrics.
  • Trend stability: The stable debt-to-equity ratio over three years points to disciplined capital allocation and limited reliance on incremental financial leverage for growth.
Adeka Corporation: History, Ownership, Mission, How It Works & Makes Money

Adeka Corporation (4401.T) - Liquidity and Solvency

Adeka Corporation (4401.T) shows solid short-term liquidity and a conservative solvency profile heading into the latter half of fiscal 2025. Operational cash generation and conservative financing combine to support working capital needs and manageable leverage.
  • Current ratio (as of September 30, 2025): 1.8 - adequate coverage of short-term obligations.
  • Quick ratio: 1.2 - sufficient liquid assets to meet immediate liabilities.
  • Operating cash flow (H1 FY2025): ¥15,000 million - a 10% increase year-over-year.
  • Free cash flow (H1 FY2025): ¥10,000 million - strong cash conversion from operations.
  • Net debt / EBITDA: 1.2 - manageable leverage relative to earnings.
  • Solvency ratio: 0.3 - indicates a conservative equity-backed financing structure.
Metric Value Notes
Current ratio (9/30/2025) 1.8 Current assets / current liabilities
Quick ratio 1.2 Excludes inventories; immediate liquidity
Operating cash flow (H1 FY2025) ¥15,000 million 10% increase vs prior period
Free cash flow (H1 FY2025) ¥10,000 million After capital expenditures
Net debt / EBITDA 1.2 Leverage measure; low-to-moderate
Solvency ratio 0.3 Equity proportion indicating conservative financing
Operational dynamics to watch include working capital turnover, capex levels that could affect free cash flow, and any material changes to debt structure that would move the net debt/EBITDA ratio. For broader context on the company's background, strategy, and how it makes money, see: Adeka Corporation: History, Ownership, Mission, How It Works & Makes Money

Adeka Corporation (4401.T) - Valuation Analysis

  • P/E ratio: 14.97 - moderate valuation relative to current earnings.
  • Forward P/E: 13.52 - suggests potential undervaluation based on projected earnings.
  • P/B ratio: 1.2 - market values the company close to book value, indicating a reasonable premium.
  • Dividend yield: 2.72%; Annual dividend: ¥104.00 per share; Ex-dividend date: March 30, 2026.
  • Analyst price targets range: ¥3,200 to ¥3,733 - implies potential upside versus prevailing market price.
Metric Value Interpretation
P/E (TTM) 14.97 Moderate valuation; earnings-priced.
Forward P/E 13.52 Lower than current P/E - expected earnings growth or re-rating.
P/B 1.2 Shares trade near book value.
Dividend Yield 2.72% Provides steady income component.
Annual Dividend ¥104.00 / share Cash return to shareholders.
Ex-Dividend Date March 30, 2026 Date to qualify for upcoming dividend.
Analyst Price Targets ¥3,200 - ¥3,733 Consensus range indicating upside potential.
  • Income vs. valuation: 2.72% yield complements a modest P/E, making Adeka attractive for income-conscious investors seeking value exposure.
  • Forward-looking signal: A forward P/E below the trailing P/E suggests analysts expect earnings improvement or margin expansion.
  • Balance-sheet context: P/B of 1.2 signals limited downside from book-value perspective while leaving room for capital appreciation if earnings grow.
Adeka Corporation: History, Ownership, Mission, How It Works & Makes Money

Adeka Corporation (4401.T) Risk Factors

Adeka Corporation (4401.T) faces multiple identifiable risk vectors that can materially affect earnings, cash flow and shareholder value. Below is a focused breakdown of the primary risk categories, their typical transmission mechanisms to financial outcomes, and illustrative sensitivity/impact metrics used by investors and analysts.
  • Raw material price volatility - direct margin pressure
Volatility in feedstock and commodity chemical prices (e.g., petroleum-derived intermediates, specialty monomers, and agricultural-derived inputs) can quickly widen or compress gross margins. For a mid-sized diversified chemical manufacturer like Adeka, raw material costs typically represent a high share of COGS; a sustained 10% rise in key feedstock prices can reduce operating margin by several hundred basis points unless offset by pricing pass-through or hedging.
  • Competitive industry dynamics - pricing and volume risk
Adeka operates in highly competitive global and domestic markets (specialty chemicals, food ingredients, polymer additives). Competitive pressures can force price reductions, increase selling and marketing spend, or require capex for product differentiation-each hurting near-term returns and potentially slowing ROIC.
  • Regulatory and environmental compliance cost risk
Tightening environmental, safety and chemical-specific regulations in Japan and export markets can increase compliance CAPEX and recurring operating costs (waste treatment, emissions controls, reporting). Noncompliance risk also raises the potential for fines or production stoppages.
  • Currency exchange rate volatility - revenue and margin translation
Adeka's international sales and procurement create FX exposure. Currency swings affect both translated consolidated results and domestic margin if input costs denominated in foreign currency cannot be fully hedged or passed through.
  • Demand cyclicality and macroeconomic downturns
Economic slowdowns in end-markets (automotive, packaging, food processing, construction) can reduce volumes and extend receivable cycles, pressuring working capital and utilization-driven fixed cost absorption.
  • Supply chain disruptions and operational continuity
Natural disasters, port delays, geopolitical events and supplier failures can interrupt inbound raw materials and outbound deliveries, leading to production disruptions, expedited freight costs, and lost sales.
Risk Category Primary Impact Channel Illustrative Sensitivity / Likely Range Mitigants
Raw material price volatility Higher COGS → lower gross margin 10% feedstock rise → ~100-300 bps margin compression Long-term contracts, limited hedging, price pass-through
Competition Price pressure, lower volumes Market share shifts ±1-3 ppt annually; margin pressure 50-200 bps R&D, product mix premiuming, customer partnerships
Regulatory / environmental Capex & operating cost increase One‑time compliance CAPEX: several billion JPY; Opex +10-50% for affected facilities Proactive upgrades, phased compliance, industry associations
FX volatility Translation losses; input cost volatility JPY moves ±5% → EBITDA swing typically low-to-mid single-digit % Natural hedges, currency hedging, local sourcing
Economic downturns Reduced demand and utilization Revenues down 5-20% in severe cyclical downturns Diversified end-markets, flexible production
Supply chain disruptions Production stoppage, higher logistics costs Single-site disruption can cut segment output by 10-40% short-term Inventory buffers, multi-sourcing, contingency plans
  • Quantitative balance-sheet and cash-flow considerations
Key balance-sheet sensitivities for investors to monitor include leverage, liquidity and working capital cycles. Scenario analysis often assumes:
  • A moderate raw material shock (10% higher) reduces free cash flow by a mid-single-digit percentage over 12 months absent price pass-through.
  • A deep demand slump (-15% revenue) can push coverage ratios towards covenant thresholds if combined with elevated CAPEX or dividend commitments.
  • Operational and strategic monitoring checklist for investors
  • Trend in gross margin vs. raw material indices and ability to pass-through costs.
  • Export vs. domestic revenue split and FX hedging disclosure.
  • Capital allocation to environmental compliance and productivity-enhancing projects.
  • Customer concentration metrics and end-market exposure (e.g., automotive, food, packaging).
  • Working capital trends (days inventory, receivables) and short-term liquidity availability.
For deeper context on shareholder composition and recent investor flows, see: Exploring Adeka Corporation Investor Profile: Who's Buying and Why?

Adeka Corporation (4401.T) - Growth Opportunities

Adeka Corporation (4401.T) aligns its ADX 2026 Mid-Term Management Plan with global sustainability and market-expansion trends, positioning the company to capitalize on higher-margin product lines and international demand while returning capital to shareholders.

  • ADX 2026 focus: increase eco-friendly product mix and reduce greenhouse gas emissions, supporting demand from sustainability-driven end markets.
  • International footprint: an international sales ratio of just under 55%, providing a platform to capture growth in emerging markets across Asia, Africa, and Latin America.
  • Portfolio strategy: prioritizing high-value product sales within the Chemicals segment to drive operating profit expansion.
  • Capital returns: share repurchase program of up to ¥18 billion aimed at enhancing shareholder value and signaling confidence to investors.
  • R&D and innovation: continued investment in new materials and specialty chemicals to lift margins and open adjacent end-markets (electronics, sustainable packaging, agrochemicals).
Metric Value / Target Relevance
ADX 2026 Horizon Through 2026 Strategic timeframe for sustainability and growth initiatives
International Sales Ratio ~55% Revenue diversification and exposure to faster-growing markets
Share Repurchase Authorization Up to ¥18 billion Potential EPS accretion and support for share price
Focus Area - Chemicals High-value product mix expansion Higher gross margins and operating profit leverage
Sustainability Direction Increase eco-friendly products; GHG reduction measures (ADX 2026) Aligns with customer procurement policies and regulatory trends
  • Emerging-market expansion rationale:
    • Leverage ~55% international sales base to scale distribution and local partnerships.
    • Target markets where demand for specialty chemicals and eco-friendly additives is rising faster than in developed markets.
  • Shareholder alignment:
    • ¥18 billion buyback can reduce float, improve ROE, and complement dividend policy to attract yield-focused and quality growth investors.
  • Operational levers to realize growth:
    • Shift sales mix toward higher-margin specialty chemicals and proprietary formulations.
    • Scale eco-friendly product lines to capture premium pricing and long-term contracts.
    • Invest in targeted M&A or licensing in regions with accelerating end-market demand.

For context on corporate priorities and the ADX 2026 alignment, see: Mission Statement, Vision, & Core Values (2026) of Adeka Corporation.

DCF model

Adeka Corporation (4401.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.